Clinical Trials for Carcinoma, Pancreatic Ductal

Find clinical trials for carcinoma, pancreatic ductal. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT ID: NCT06447662

This clinical trial is studying a new medication called PF-07934040 to understand how safe it is and how well it works for people with advanced solid tumors that have a specific genetic change know...

Recruiting

Phase: PHASE1 Type: interventional Locations: Durham, North Carolina, United States, Saint Louis, Missouri, United States +24 more

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

NCT ID: NCT06974734

This clinical trial is looking at a new treatment called PF-08046037, either by itself or combined with another drug called sasanlimab, for patients with certain advanced cancers. Specifically, the...

Recruiting

Phase: PHASE1 Type: interventional Locations: Grand Rapids, Michigan, United States, Rio Piedras, , Puerto Rico

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

NCT ID: NCT06704724

This clinical trial is studying a new medicine called PF-07985045 to see how safe it is and how well it works in treating advanced solid tumors, which are lumps of abnormal cells in the body. The t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States +10 more

Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures

NCT ID: NCT05475366

This clinical trial is investigating how to choose the best first-line chemotherapy treatment for patients with advanced pancreatic cancer. The researchers want to see if they can improve treatment...

Recruiting

Phase: NA Type: interventional Locations: Créteil, , France, Reims, , France +4 more

Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

NCT ID: NCT05461430

The TraveraRTGx clinical trial is studying a new way to help doctors choose the best treatment for patients with different types of cancer. The trial focuses on looking at tumor cells found in flui...

Recruiting

Type: observational Locations: Oakland, California, United States

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

NCT ID: NCT06573398

This clinical trial is studying a new treatment approach for borderline resectable pancreatic cancer, a type of cancer that is tricky to treat but might be operable with the right therapy. The trea...

Not yet recruiting

Phase: PHASE2 Type: interventional

A Cohort Study on Screening and Follow-up of High-risk Population of PDAC Based on EUS

NCT ID: NCT05621824

This clinical trial is studying how to better screen and follow up with individuals who are at high risk for pancreatic cancer, specifically a type called pancreatic ductal carcinoma (PDAC). The re...

Not yet recruiting

Type: observational

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions